STOCK TITAN

The Watchlist by The Market Herald Releases New Interviews with Nextech3D.ai and Medicus Pharma Discussing their Latest News

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
AI
Rhea-AI Summary
The Watchlist by The Market Herald releases new interviews with Nextech3D.ai and Medicus Pharma
Positive
  • Nextech3D.ai provides business updates on its business units powered by AI, 3D, AR, and ML
  • Medicus Pharma announces commencement of trading on TSX Venture Exchange
Negative
  • None.

VANCOUVER, BC / ACCESSWIRE / October 11, 2023 / The Watchlist by The Market Herald has announced the release of new interviews with Nextech3D.ai and Medicus Pharma discussing their latest news.

The Watchlist by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Nextech3D.ai Provides Business Updates on Its Business Units Powered by AI, 3D, AR and ML

Nextech3D.AI (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohls and other major e-commerce retailers has provided an update to the Company's investors on its four business units. As a diversified technology Company, each of its businesses ARitize3D, MapD, Toggle3D.ai, ARway.ai delivers a solution powered by ​proprietary AI, 3D, AR, ​and ML.

For the full interview with CEO Evan Gappelberg and to learn more about Nextech3D.ai's news, click here.

Medicus Pharma Ltd. Announces Commencement of Trading on TSX Venture Exchange and Appointment of Seasoned Pharma Executive Barry Fishman to the Board of Directors

Medicus Pharma Ltd. (TSXV:MDCX) has announced that it will commence trading on the TSX Venture Exchange on October 11th, 2023. The initial trading price is CDN $2.75.

For the full interview with CEO Raza Bokhari and to learn more about Medicus Pharma's news, click here.

Interviews for The Watchlist by The Market Herald are released daily. To learn more about the companies featured in The Watchlist or to explore our other interviews visit The Watchlist by The Market Herald.

About The Market Herald

The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.

CONTACT:

The Market Herald
marketing@themarketherald.ca
themarketherald.ca

SOURCE: The Market Herald



View source version on accesswire.com:
https://www.accesswire.com/792133/the-watchlist-by-the-market-herald-releases-new-interviews-with-nextech3dai-and-medicus-pharma-discussing-their-latest-news

FAQ

What updates did Nextech3D.ai provide?

Nextech3D.ai provided updates on its four business units powered by AI, 3D, AR, and ML.

When will Medicus Pharma commence trading on TSX Venture Exchange?

Medicus Pharma will commence trading on October 11th, 2023.

What is the initial trading price for Medicus Pharma?

The initial trading price for Medicus Pharma is CDN $2.75.

NEXTECH3D AI CORP

OTC:NEXCF

NEXCF Rankings

NEXCF Latest News

NEXCF Stock Data

4.18M
132.32M
7.82%
Internet Retail
Consumer Cyclical
Link
United States of America
Toronto